Method for improving iron ion loading rate of euphausia superba protein amyloid fiber and application

By using ultrasound to process Antarctic krill protein amyloid fibers, their microstructure was regulated, and a high-load Antarctic krill protein amyloid fiber-iron complex was prepared. This solved the problem of insufficient iron ion loading, improved antioxidant and emulsifying properties, and enhanced iron bioavailability and iron deficiency anemia.

CN122056384APending Publication Date: 2026-05-19DALIAN POLYTECHNIC UNIVERSITY
View PDF 1 Cites 0 Cited by

Patent Information

Application Number
CN202610237512.2
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2026-02-28
Publication Date
2026-05-19

AI Technical Summary

Technical Problem

The iron ion loading effect of the Antarctic krill protein amyloid fiber-iron complex in the existing technology is insufficient, which cannot meet the needs of multifunctional materials in functional food processing, and lacks the ability to improve key functional properties of amyloid fiber such as anti-oxidation and emulsification.

Method used

Antarctic krill protein amyloid cellulose-iron complex was prepared by ultrasonic treatment to regulate its microstructure and activate iron ion binding sites. The process included ultrasonic treatment, pH adjustment, heating and freeze drying to form a complex with a high loading rate.

Benefits of technology

It significantly improved the antioxidant and emulsifying properties of Antarctic krill protein amyloid fibers, increased iron loading by 20.19%~22.5%, and significantly improved iron bioavailability, thus improving iron deficiency anemia.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN122056384A_ABST
    Figure CN122056384A_ABST
Patent Text Reader

Abstract

The invention discloses a method for improving the iron ion loading rate of antarctic krill protein amyloid fiber and application, and belongs to the technical field of functional food. The method for improving the iron ion loading rate of the euphausia superba protein amyloid fiber comprises the following steps: dispersing euphausia superba protein powder in water, adjusting the pH value, fully stirring, carrying out ultrasonic treatment before heating or ultrasonic treatment after heating, freeze-drying, then adding into water, adjusting the pH value, adding ascorbic acid and FeSO4. 7H2O, reacting, filtering, washing, and drying to obtain the iron ion loading rate of the euphausia superba protein amyloid fiber. After the reaction is finished, centrifugally collecting supernate, adding absolute ethyl alcohol, standing and precipitating, centrifugally collecting precipitate, washing and drying to obtain an antarctic krill protein amyloid fiber-iron compound; the euphausia superba protein amyloid fiber-iron compound obtained by the method has better iron loading rate and iron utilization rate, can improve symptoms caused by iron-deficiency anemia, and has wide application prospects in the fields of iron-deficiency anemia improving preparations, functional food additives and the like.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] This invention relates to a method and its application for improving the iron loading rate of Antarctic krill protein amyloid fibers, belonging to the field of functional food technology. Background Technology

[0002] Amyloid fibrils mostly exhibit a crisscross pattern β Structured aggregates characterized by folded structures exhibit high order, high aspect ratio, mechanical stiffness, and a large number of active functional groups on their surface. These properties endow them with superior functional properties, including emulsification, gelation, and antioxidant capabilities, enabling their application in various technical fields such as emulsion preparation, gel system construction, and nutrient delivery.

[0003] Previous studies have shown that composite iron supplements prepared by loading iron ions onto protein amyloid fibers can effectively reduce the gastrointestinal irritation of traditional chemically synthesized iron supplements and improve the bioavailability of iron ions, and have important application value in the fields of food fortification and the development of new iron supplements.

[0004] For example, Chinese patent CN119924532A discloses an Antarctic krill protein amyloid fiber-iron complex and its preparation method and application. This scheme initially realizes the preparation of Antarctic krill protein amyloid fiber-iron complex and improves the bioavailability of iron to a certain extent. However, the iron ion loading effect is still insufficient, and it lacks the ability to improve the key functional properties of amyloid fiber such as anti-oxidation and emulsification, which cannot meet the actual needs of multifunctional materials in functional food processing. Summary of the Invention

[0005] To address the shortcomings of existing technologies, the present invention aims to provide a method and application for improving the iron loading rate of Antarctic krill protein amyloid fibers. Specifically, this method involves ultrasonic treatment of Antarctic krill protein to regulate the microstructure of Antarctic krill protein fibers, activate iron ion binding sites, and thus significantly improve the iron loading rate. The resulting high-loading Antarctic krill protein amyloid fiber-iron complex can be applied in functional health products, fortified foods, and other fields.

[0006] To achieve the above objectives, the following technical solution is provided: The first objective of this invention is to provide a method for increasing the iron loading rate of Antarctic krill protein amyloid fibers, the method comprising the following steps: (1) Disperse Antarctic krill protein powder in water to form a solution, adjust the pH, stir thoroughly, let stand, sonicate, heat, freeze dry to obtain Antarctic krill protein starch-like fibrils; Alternatively, Antarctic krill protein powder can be dispersed in water to form a solution, the pH adjusted, stirred thoroughly, allowed to stand, heated, sonicated, and freeze-dried to obtain Antarctic krill protein starch-like fibrils. (2) The Antarctic krill protein amyloid fibrils obtained in step (1) were added to water to form a solution, the pH was adjusted, ascorbic acid and FeSO4·7H2O were added to react, the supernatant was collected by centrifugation after the reaction was completed, anhydrous ethanol was added and allowed to stand to precipitate, centrifuged, the precipitate was collected, washed and dried to obtain the Antarctic krill protein amyloid fibrils-iron complex.

[0007] In one embodiment, the Antarctic krill protein powder in step (1) is commercially available or homemade.

[0008] In one embodiment, the preparation process of the Antarctic krill protein powder is as follows: After mixing the chopped Antarctic krill meat with water, adjust the pH to 12.5, stir, centrifuge, take the supernatant, adjust the pH to 4.5, continue stirring, centrifuge to obtain protein precipitate, adjust the pH of the protein precipitate to 7.0, dialyze, freeze dry, and obtain Antarctic krill protein powder AKP.

[0009] In one embodiment, the concentration of Antarctic krill protein in the solution of step (1) is 10~20 mg / mL.

[0010] In one embodiment, step (1) involves adjusting the pH value to 2.0 to 4.0.

[0011] In one embodiment, the time for thorough stirring in step (1) is 6 to 8 hours.

[0012] In one implementation, the resting conditions in step (1) are: overnight in a refrigerator at 2~6°C.

[0013] In one embodiment, the ultrasonic treatment conditions in step (1) are: power of 200~300 W, time of 5~45 min, 5 s on / 5 s off.

[0014] In one embodiment, the ultrasonic treatment conditions in step (1) are: power of 240 W and time of 5 to 45 min; preferably 5 to 15 min.

[0015] In one embodiment, the ultrasonic treatment conditions in step (1) are: power of 240 W and time of 5 min.

[0016] In one embodiment, the ultrasonic treatment conditions in step (1) are: power of 240 W and time of 15 min.

[0017] In one embodiment, the heating temperature in step (1) is 85~95°C and the time is 2~6 h; preferably, the temperature is 90°C and the time is 4 h.

[0018] In one embodiment, the solution is placed in ice water during the ultrasound process in step (1).

[0019] In one embodiment, the concentration of Antarctic krill protein amyloid fibrils in the solution in step (2) is 20~40 mg / mL.

[0020] In one embodiment, step (2) involves adjusting the pH value to 6.0 to 8.0; preferably, the pH value is 6.0.

[0021] In one embodiment, the amount of ascorbic acid added in step (2) is 0.5 to 1.0% (g / mL) of the volume of the amyloid cellulose solution.

[0022] In one embodiment, the mass ratio of FeSO4·7H2O to Antarctic krill protein amyloid fibers in step (2) is 1:2.

[0023] In one embodiment, the reaction in step (2) is carried out at a temperature of 25-30°C for 40-60 min.

[0024] In one embodiment, the washing in step (2) is specifically performed using ethanol.

[0025] A second objective of this invention is to provide an Antarctic krill protein amyloid fiber-iron complex obtained by the method described above.

[0026] A third objective of this invention is to provide the application of the aforementioned Antarctic krill protein amyloid fiber-iron complex in the preparation of iron-rich foods or iron supplements.

[0027] A fourth objective of this invention is to provide a method for improving the bioavailability of Antarctic krill protein amyloid fiber-iron complex, the method comprising the following steps: (1) Disperse Antarctic krill protein powder in water to form a solution, adjust the pH, stir thoroughly, let stand, sonicate, heat, freeze dry to obtain Antarctic krill protein starch-like fibrils; Alternatively, Antarctic krill protein powder can be dispersed in water to form a solution, the pH adjusted, stirred thoroughly, allowed to stand, heated, sonicated, and freeze-dried to obtain Antarctic krill protein starch-like fibrils. (2) Add the Antarctic krill protein amyloid fibrils obtained in step (1) to water to form a solution, adjust the pH, add ascorbic acid and FeSO4·7H2O to react, centrifuge to collect the supernatant after the reaction, add anhydrous ethanol to stand and precipitate, centrifuge to collect the precipitate, wash and dry to obtain the Antarctic krill protein amyloid fibrils-iron complex.

[0028] Beneficial effects: Compared with the prior art, the present invention has the following advantages: (1) This invention effectively improves the functional properties of Antarctic krill protein amyloid fibers by sonicating them, resulting in high antioxidant properties, good emulsification properties, and significantly increased iron loading. Compared with untreated Antarctic krill protein amyloid fibers, the sonication method of this invention, involving both pre-fibrillation (before heating) and post-fibrillation (after heating) of the Antarctic krill protein, resulted in a 20.19% and 22.5% increase in iron binding capacity, respectively. post -AF has significantly higher iron binding than U. pre -AF; (2) The present invention utilizes an Antarctic krill amyloid fiber-iron complex obtained by ultrasonic treatment, which can improve the bioavailability of iron and effectively improve iron deficiency anemia. post The hemoglobin content of mice in the AF-Fe group was not only superior to that in the untreated AF-Fe group and the U group, but also... pre The -AF-Fe group showed that hemoglobin levels recovered to a level that was not significantly different from the normal control group. Attached Figure Description

[0029] Figure 1 The image shows the thiamine T (ThT) of Antarctic krill amyloid fibers obtained under different ultrasound times in Example 1. Figure 2 shows the thiosulfate T (ThT) diagram of Antarctic krill amyloid fibers obtained under different ultrasound times in Example 2; Figure 3 shows cold field scanning electron microscopy images of Antarctic krill starch-like fibers obtained under the following conditions: no ultrasound, ultrasound before heat treatment, and ultrasound after heat treatment. Figure 4 shows the effect of Fe on Antarctic krill starch-like fibers obtained under the following conditions: no ultrasound, ultrasound before heat treatment, and ultrasound after heat treatment. 3+ Reduction capability chart; Figure 5 shows the emulsification properties of Antarctic krill starch-like fibers obtained under the following conditions: no ultrasound, ultrasound before heat treatment, and ultrasound after heat treatment. Figure 6 shows the iron-binding capacity of Antarctic krill starch-like fibers obtained under the following conditions: no ultrasound, ultrasound before heat treatment, and ultrasound after heat treatment. Figure 7 shows the infrared spectra of Antarctic krill starch-iron complexes obtained under the following conditions: no ultrasound, ultrasound before heat treatment, and ultrasound after heat treatment. Figure 8 shows the simulated in vitro digestion results of Antarctic krill starch-iron complex obtained under the following conditions: no ultrasound, ultrasound before heat treatment, and ultrasound after heat treatment. Figure 9 shows the effect of Antarctic krill amyloid fiber-iron complex obtained under the conditions of no ultrasound, ultrasound before heat treatment, and ultrasound after heat treatment on the body weight of mice with iron deficiency anemia. Figure 10 shows the effect of Antarctic krill amyloid fiber-iron complex obtained under the conditions of no ultrasound, ultrasound before heat treatment, and ultrasound after heat treatment on the spleen coefficient of iron-deficiency anemia mice. Detailed Implementation

[0030] The technical solutions in the embodiments of the present invention will be clearly and completely described below. Obviously, the described embodiments are only a part of the embodiments of the present invention, and not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by those skilled in the art without creative effort are within the scope of protection of the present invention. The specific embodiments described below further illustrate the present invention.

[0031] The source of the materials involved in this invention: The frozen Antarctic krill meat was purchased from Dalian Ocean Fishery Group Co., Ltd.

[0032] Example 1 A method for preparing an Antarctic krill protein amyloid fiber-iron complex includes the following steps: S1. Extraction of Antarctic krill protein: Chopped Antarctic krill meat was mixed with deionized water at a ratio of 1:10 (w / v, g / mL). After stirring for 10 minutes, the mixture was adjusted to pH 12.5 with 2M NaOH. After stirring at 4°C for 2 hours, it was centrifuged at 10,000 × g for 10 minutes at 4°C. The supernatant was adjusted to pH 4.5 with 2M HCl and stirred for 30 minutes. The precipitate was obtained by centrifugation, and the pH of the protein precipitate was adjusted to 7.0. The protein solution was then dialyzed for 48 hours and freeze-dried to obtain Antarctic krill protein AKP. S2. Weigh out Antarctic krill protein and disperse it in deionized water to a concentration of 10 mg / mL. Adjust the pH to 2.0, stir for 6 h, and place in a 4°C refrigerator overnight to obtain a fully acidified Antarctic krill protein solution (AKP). S3. The AKP solution obtained in step S2 is dispensed into 10 mL solutions, and then the solutions are placed in ice water for ultrasonic treatment for 5 min, 15 min, 25 min, 35 min and 45 min respectively, with an ultrasonic power of 240 W, to obtain the AKP solution before heat treatment. S4. The AKP solution obtained in step S3 before heat treatment and ultrasonication is heated in a water bath at 90°C for 4 hours, and then freeze-dried to obtain Antarctic krill protein amyloid fibers (U... pre -AF); S5, Weigh U pre -AF15 Antarctic krill protein amyloid fiber powder was mixed with deionized water to prepare an Antarctic krill protein amyloid fiber solution (20 mg / mL). The pH was adjusted to 6.0. Ascorbic acid was added to the solution at 0.5% (g / mL) of the solution volume. FeSO4·7H2O was added at a mass ratio of 1:2 to the Antarctic krill protein amyloid fiber and mixed thoroughly. The mixture was reacted at 30°C for 40 min. The mixture was centrifuged to collect the supernatant, and 5 times the volume of anhydrous ethanol was added. The mixture was allowed to stand for 30 min to allow complete precipitation. The ethanol was removed by centrifugation to obtain U pre The -AF-Fe complex was washed with ethanol, this operation was repeated 4 times to remove excess iron ions, and then dried to obtain U. pre -AF-Fe powder.

[0033] Example 2 A method for preparing an Antarctic krill protein amyloid fiber-iron complex includes the following steps: S1. Extraction of Antarctic Krill Protein: Chopped Antarctic krill meat was mixed with deionized water at a ratio of 1:10 (w / v, g / mL). After stirring for 10 minutes, the mixture was adjusted to pH 12.5 with 2M NaOH. After stirring at 4°C for 2 hours, it was centrifuged at 10,000 × g for 10 minutes at 4°C. The supernatant was adjusted to pH 4.5 with 2M HCl and stirred for 30 minutes. The precipitate was obtained by centrifugation, and the pH of the protein precipitate was adjusted to 7.0. The protein solution was then dialyzed for 48 hours and freeze-dried to obtain Antarctic krill protein (AKP). S2. Weigh out Antarctic krill protein powder, disperse it in deionized water to a concentration of 10 mg / mL, adjust the pH to 2.0, stir for 6 h, and place in a 4°C refrigerator overnight to obtain a fully acidified Antarctic krill protein solution (AKP). S3. The AKP solution obtained in step S1 was dispensed into 10 mL portions and heated in a water bath at 90°C for 4 h to obtain Antarctic krill protein amyloid fibers (AF). S4. The Antarctic krill protein amyloid fiber (AF) solution obtained in step S3 was subjected to sonication in ice water for 5 min, 15 min, 25 min, 35 min, and 45 min, with a sonication power of 240 W. The solution was then freeze-dried to obtain Antarctic krill protein amyloid fiber (U... post -AF); S5, Weigh U post -AF5 Antarctic krill protein amyloid fiber powder was mixed with deionized water to prepare an Antarctic krill protein amyloid fiber solution (20 mg / mL). The pH was adjusted to 6.0. Ascorbic acid was added to the solution at 0.5% of the solution volume. FeSO4·7H2O was added at a mass ratio of 1:2 to the Antarctic krill protein amyloid fiber. The mixture was thoroughly mixed and reacted at 30°C for 40 min. The mixture was centrifuged, and the supernatant was collected. Five volumes of anhydrous ethanol were added, and the mixture was allowed to stand for 30 min to allow complete precipitation. The ethanol was removed by centrifugation to obtain U post The -AF-Fe complex was washed with ethanol, this operation was repeated 4 times to remove excess iron ions, and then dried to obtain U. post -AF-Fe powder.

[0034] Comparative Example 1 The only difference from Example 1 is that step (3) is omitted to obtain untreated AF. After that, all other parameters and conditions are the same as in Example 1 to obtain untreated AF-Fe.

[0035] Result characterization 1. Fluorescence spectrum of thiosulfate T (ThT) A 0.8 mg / mL ThT solution was prepared by dispersing ThT powder in phosphate buffer (10 mM, pH 7.0, 150 mM NaCl), and the ThT stock solution was obtained by passing the solution through a 0.22 μm syringe filter. The ThT stock solution was diluted 50-fold with PBS to obtain the ThT working solution. Then, 30 μL of sample solution was mixed with 3 mL of ThT working solution, and the reaction was carried out in the dark for 5 min. The wavelength range of 450–600 nm was scanned using a fluorescence spectrophotometer with an excitation wavelength of 440 nm.

[0036] Experimental results: ThT fluorescence is widely used to monitor the formation of protein nanofibers because ThT can specifically bind to amyloid fibrous molecules. β - Folded structure. For example... Figure 1 and 2 As shown, compared with untreated amyloid fibers, U preIn the -AF group, the fluorescence intensity of amyloid fibers significantly increased at 15 minutes, indicating that ultrasound pretreatment within 15 minutes was beneficial in accelerating amyloid fiber formation. However, when the ultrasound duration was extended to 25-45 minutes, the ThT fluorescence intensity decreased instead. post - ThT fluorescence analysis in the AF group showed that with increasing ultrasound duration, U post The fluorescence intensity of -AF initially increases and then decreases, reaching a peak at 5 minutes. This effect may be due to the short-duration ultrasound within 5 minutes dispersing tangled fibers and exposing more ThT binding sites.

[0037] 2. Secondary structure determination The circular dichroism (CD) spectrum of the sample solution (0.1 mg / mL) was analyzed in the wavelength range of 190 to 260 nm. Calculations were performed. α -spiral, β Layers, β - The content of turns and random coils is used for secondary structure estimation.

[0038] Table 1. Content of secondary structure of amyloid fibers in ultrasound-regulated Antarctic krill

[0039] Experimental results: Compared with untreated AF, U pre -AF15 exhibits reduced α-helix and increased β-fold, with minimal effect on β-turn and random coiling. U post -AF5 then increases β - While folding, it significantly reduces the β-turn angle, increases random coiling, and increases the α-helix content. Both ultrasonic processing methods improve... β The folding ratio indicates that ultrasound can promote the aggregation of amyloid fibers and the formation of an ordered structure.

[0040] 3. Microscopic morphological observation A 10 μL sample was dropped onto the sample stage and rapidly frozen with liquid nitrogen. After sublimation (-90 °C, 40 min), the sample was cut to form a cross-section, sputtered with gold, and the microstructure of the sample was observed using a scanning electron microscope at an accelerating voltage of 10.0 kV.

[0041] Experimental results: Cold field scanning electron microscopy (SEM) of the obtained Antarctic krill protein amyloid fibers ( Figure 3 Untreated AF was observed to have a long, entangled, curved fiber morphology. pre -AF15 exhibits a more ordered and dispersed state, with more straight and short fibrils. U post -AF5 shows dispersed, relatively uniform aggregates of worm-like fibers.

[0042] 4. Fe 3+ Reducing power determination Determination of AF on Fe 3+ The reducing power was determined. 2.5 mL of phosphate buffer and 2.5 mL of potassium ferricyanide (10 mg / mL) were added to 1 mL of sample (5 mg / mL) solution, mixed thoroughly, and incubated in a 50°C water bath for 20 min. Then, 2.5 mL of trichloroacetic acid (100 mg / mL) solution was added, vortexed, and centrifuged at 8000 × g for 5 min at room temperature. 2.5 mL of the supernatant was then mixed with 2.5 mL of water and 0.5 mL of ferric chloride (1 mg / mL), reacted for 10 min, and the absorbance was measured at 700 nm. Experimental results: Figure 4 As shown, U pre -AF15 has higher reducing power than untreated AF because the degree of protein fibrillation affects the reduction of Fe by protein amyloid fibers. 3+ The reducing power has a significant impact. Specifically, the degree of fibrillation of AF (acid-free protein) is greatest during the first 15 minutes of sonication before heating, resulting in more exposure of reducing groups on the protein fibrils. The reducing power of fibrils for a certain amount of FeCl3 is... 2+ The production of ferrous oxide increases with the level of fibrillation. Therefore, ultrasonic treatment of AF for a certain period of time before heat treatment can improve the iron reduction ability of AF. U post -AF5 for Fe 3+ The reducing power of the AF is also significantly higher than that of the untreated AF. This is because ultrasound promotes the unfolding and dispersion of long and entangled fibrils, allowing the AF to expose more redox residues.

[0043] 5. Emulsifying Activity (EAI) and Emulsifying Stability (ESI) Tests Amyloid cellulose solution was mixed with soybean oil (3:1, w / w) and then sheared at high speed (10000 rpm, 1 min) using a high-speed shearing machine. At 0 and 10 min, aliquots (50 μL) of the emulsion were immediately removed from the bottom of the emulsion and dispersed in 5 mL of 0.1% (w / v) SDS solution. Absorbance values ​​were measured at 500 nm using a spectrophotometer, with the SDS solution used as a blank. EAI and ESI were calculated according to equations (1) and (2), respectively. Where c is the initial protein concentration (g / mL), ε is the oil ratio, D is the dilution factor, A0 is the absorbance at 0 min, and A 10 The absorbance is measured over 10 minutes, and L is the diameter of the cuvette, which is 1 cm.

[0044] Emulsifying Activity Index: EAI (m 2 / g)=2*2.303*A*10-4 / (1-ε) Emulsion stability index: ESI (%) = A 10 / A0*100 Experimental results: such as Figure 5 As shown, compared to untreated AF, U pre -AF15 exhibits good emulsification stability, U post- AF5 exhibits excellent emulsifying activity. Under ultrasonic treatment, protein molecules fully expand, making it easier to form a dense, highly cross-linked amyloid fibrous network during subsequent heat treatment. This network structure has higher mechanical strength at the oil-water interface, effectively preventing droplet aggregation and thus improving emulsification stability. Therefore, U pre -AF15 exhibits good emulsifying stability. Ultrasonic treatment following heat treatment allows the formed amyloid fibers to generate more active sites and short fibrils, increasing the surface area in contact with the oil phase and thus significantly improving emulsifying activity. Therefore, different stages of ultrasonic treatment can produce varying degrees of improvement in emulsifying activity and emulsifying stability.

[0045] 6. Fe 2+ Binding capacity test Pipette 0, 0.4, 0.8, 1.2, 1.6, and 2.0 mL of 100 mg / L iron standard intermediate solution into 50 mL volumetric flasks, respectively. Add 1 mL of HCl (1.0 mol / L) solution, 1.0 mL of hydroxylamine hydrochloride (10%) solution, 1.0 mL of o-phenanthroline (0.12%) solution, and 5.0 mL of sodium acetate buffer solution (pH 4.5) sequentially to the volumetric flasks. Dilute to the mark with deionized water, using deionized water as a blank control. Measure the absorbance at 510 nm and plot the iron ion standard curve. Take a certain amount of the AF-Fe complex, add HCl (6 M) for hydrolysis to fully release the iron ions in the complex, dilute to the mark, and measure the absorbance of the sample according to the standard curve determination procedure. The formula for calculating the iron content of the complex is as follows: Iron chelation rate (%) = Iron content in solution * Solution volume / Total sample mass * 100 Experimental results: such as Figure 6 As shown, U pre -AF showed significantly enhanced iron chelating ability. Compared with the control group (46.37%), U pre -AF15 increased the iron chelation rate to 66.56%. U post -AF5 also exhibited a similar enhancement phenomenon, in which U post The iron chelation rate of -AF5 reached 68.87%. These improvements are attributed to structural changes that occur during the fibrosis process. These changes expose a large number of carboxyl and amino groups, thereby chelating ferrous ions (Fe²⁺). + ) provides binding sites.

[0046] 7. Infrared spectrum The sample was mixed with potassium bromide, ground, and extruded into a sheet. The sample was then scanned using a Fourier transform infrared spectroscopy (FTIR) instrument. The scan range was 400–4000 cm⁻¹. -1 Range scanning, instrument resolution 4 cm -1 Infrared spectra were obtained.

[0047] Experimental results: Figure 7 This indicates that untreated AF-Fe and U pre -AF15-Fe and U post The Fourier transform infrared spectrum of the -AF5-Fe complex changed after the introduction of iron ions. The absorption peaks of the NH and OH groups changed from 3294 cm⁻¹. - ¹、3295 cm - ¹ and 3293 cm - ¹Moved to 3341 cm respectively - ¹、3343 cm - ¹ and 3356 cm - ¹ This indicates that a new coordination bond was formed between the -NH / -OH group and the iron ion. The characteristic amide I peak in all samples underwent a red shift, from 1657–1658 cm⁻¹. - ¹Transferred to 1659 cm - ¹ indicates that the C=O group participates in the bonding of iron. Furthermore, the absorption peak of the -COOH group extends from approximately 1406 cm⁻¹. - ¹ Moved to 1388 cm - ¹ This may be due to the formation of a -COO-Fe complex by the combination of iron with the C-terminal carboxyl group and residues of glutamic acid and aspartic acid. Furthermore, in all complexes, at 1123 cm⁻¹... - The strong absorption peaks near ¹ further indicate the formation of a CO-Fe complex. These findings suggest that untreated AF-Fe, U pre -AF15-Fe and U post The carboxyl, hydroxyl, amino, and amide groups in -AF5-Fe participate in coordination with iron ions to varying degrees.

[0048] 8. Simulating in vitro gastrointestinal digestion Combine FeSO4, untreated AF-Fe, U pre -AF15-Fe and U post-AF5-Fe and simulated gastric and intestinal solutions were incubated in a water bath at 37°C for 10 min. The pH was then adjusted to 3.0 using 1 mol HCl. Pepsin was then added at an enzyme-substrate ratio of 1:50 (w / w) for digestion at 0, 30, 60, 90, and 120 min. 1 mL of digest was collected at each time point and immediately placed in an ice-water mixture to inhibit enzyme activity. Subsequently, the pH was adjusted to 6.8 using 1 mol NaOH, and trypsin was added for intestinal digestion. 2 mL of intestinal digestion products were collected at 0, 30, 60, 90, and 120 min. After ice bath, the digestion products were transferred to dialysis bags to remove free iron ions. The iron release rate from the digestion products was determined using atomic absorption spectrometry.

[0049] Experimental results: such as Figure 8 As shown, after the 120-minute gastric digestion phase, the iron release rate of FeSO4 was as high as 64.70%, while that of untreated AF-Fe was 57.95%. pre The iron release rate of -AF15-Fe is 48.48%, U post The release rate of AF5-Fe was 54.09%. At the end of the intestinal digestion phase, the iron release rate of FeSO4 decreased to 3.40%, and untreated AF5-Fe and U... pre -AF15-Fe and U post The iron release rates of -AF5-Fe decreased to 19.61%, 24.11%, and 24.01%, respectively. At each stage of digestion, untreated AF-Fe and U... pre -AF15-Fe and U post The bioavailability of iron in -AF5-Fe was consistently higher than that in FeSO4, indicating that ultrasound-regulated Antarctic phosphoprotein amyloid fibers can effectively regulate particle size and solubility, thereby improving the release characteristics of iron in the intestine.

[0050] Application Examples Sixty SPF-grade, three-week-old female C57 / B6 mice were purchased from Liaoning Changsheng Biotechnology Co., Ltd. and housed in an SPF-grade animal laboratory. During the experiment, the mice had free access to food and water. After one week of acclimatization, the 60 mice were randomly divided into 6 groups using a random number table. Ten mice served as the normal control group, fed a standard diet (normal feed, iron content 45 ppm) until the end of the experiment. The remaining mice were divided into five groups and fed an iron-deficient diet (iron-deficient feed, iron content 12 ppm) for eight weeks to establish an iron deficiency anemia (IDA) mouse model. Blood was collected from the orbital region of the mice and measured using a hemoglobin (Hb) kit; Hb less than 100 g / L was defined as iron deficiency anemia. After the iron deficiency model was established, the experimental groups were randomly divided into five groups according to hemoglobin content and mouse weight. Except for the normal control group, the mice continued the iron-deficient diet for three weeks. During this period, the normal control group and the model group mice were administered deionized water by gavage daily; the other groups were administered the corresponding iron supplements by gavage daily. Model (IDA) group: Daily gavage with deionized water; FeSO4 group: 2 Fe / kg BW (calculated as elemental iron) were administered by gavage daily. untreated AF-Fe group: 2 Fe / kgBW; U pre -AF15-Fe group: 2 Fe / kgBW; U post -AF5-Fe group: 2 Fe / kgBW; Mice body weight was monitored weekly during the experiment, and the dosage of iron supplements was adjusted accordingly. The recommended iron intake for adult women (18-60 kg) in the "Chinese Dietary Reference Intakes" was followed, and equivalent dose conversion was performed according to the "Guidelines for Dosage Conversion between Animals and Humans." Twelve hours after the last gavage, mice were euthanized, and their livers and spleens were collected for subsequent experiments.

[0051] 1. Results of mouse body weight change Mouse weight changes as follows Figure 9 As shown, after an iron-deficient diet (0 weeks), there was no significant difference in body weight in the iron-deficient diet group, but compared with the normal control group, their body weight was significantly lower. Therefore, IDA affects the growth and development of mice. Furthermore, iron supplementation for IDA mice was achieved through the ingestion of FeSO4, untreated AF-Fe, and U... pre -AF15-Fe and U post -AF5-Fe for 3 consecutive weeks. Untreated AF-Fe and U were found. pre -AF15-Fe and U post The body weight of the AF5-Fe group was significantly different from that of the Model group, indicating that AF-Fe can improve the problem of slow growth and development in mice.

[0052] 2. Effect of krill protein amyloid fiber-iron complex (AF-Fe) on liver coefficient in iron-deficiency anemic mice. Completely dissect the heart, liver, spleen, and kidney tissues of all mice on ice, weigh them quickly, record all data, and calculate the organ coefficients according to the following formula: Liver coefficient (%) = organ mass / mouse body weight * 100 The results showed that the liver coefficient in mice was as follows: Figure 10 IDA mice showed significant spleen enlargement, and the results indicated that iron supplementation could reverse the spleen enlargement to normal levels. The liver coefficient of IDA mice was also affected; the livers of the Model group were significantly larger than those of the iron-fortified group and the normal control group, but the effect of FeSO4 iron supplementation was not as good as that of other iron-supplemented groups.

[0053] 3. Effects of Antarctic krill protein amyloid fiber-iron complex (AF-Fe) on serum parameters in iron-deficiency anemic mice. The BC-2800vet fully automated blood cell analyzer was used to measure blood cell parameters, including hemoglobin (HGB), red blood cell count (RBC), hematocrit (HCT), mean corpuscular volume (MCV), mean corpuscular hemoglobin (MCH), and red blood cell distribution width (RDW).

[0054] Table 2. Effects of Antarctic krill protein amyloid fiber-iron complex (AF-Fe) on blood count parameters in iron-deficiency anemic mice.

[0055] The results showed that the levels of HGB, RBC, HCT, MCV, and MCH in the IDA group were significantly lower than those in the Control group, while the RDW was significantly higher in the IDA group. Mice in different AF-Fe complex intervention groups showed similar or better levels of HGB, RBC, HCT, MCV, MCH, and RDW compared to the FeSO4 group, indicating that different forms of iron supplementation have different iron-supplementing effects. Among these, U... post -AF15-Fe was more effective at supplementing iron than the other three groups of different iron supplements.

[0056] The embodiments provided above are not intended to limit the scope of the invention, nor are the described steps intended to limit the order of execution. Any obvious modifications made to the invention by those skilled in the art based on existing common knowledge also fall within the scope of protection defined by the claims.

Claims

1. A method for improving the iron loading rate of Antarctic krill protein amyloid fibers, characterized in that, The method includes the following steps: (1) Disperse Antarctic krill protein powder in water to form a solution, adjust the pH, stir thoroughly, let stand, sonicate, heat, freeze dry to obtain Antarctic krill protein starch-like fibrils; Alternatively, Antarctic krill protein powder can be dispersed in water to form a solution, the pH adjusted, stirred thoroughly, allowed to stand, heated, sonicated, and freeze-dried to obtain Antarctic krill protein starch-like fibrils. (2) Add the Antarctic krill protein amyloid fibrils obtained in step (1) to water to form a solution, adjust the pH, add ascorbic acid and FeSO4·7H2O to react, centrifuge to collect the supernatant after the reaction, add anhydrous ethanol to stand and precipitate, centrifuge to collect the precipitate, wash and dry to obtain the Antarctic krill protein amyloid fibrils-iron complex.

2. The method according to claim 1, characterized in that, The concentration of Antarctic krill protein in the solution described in step (1) is 10~20 mg / mL.

3. The method according to claim 1, characterized in that, The pH value is adjusted to 2.0~4.0 in step (1).

4. The method according to claim 1, characterized in that, The ultrasonic treatment conditions in step (1) are: power of 200~300 W, time of 5~45 min, 5 s on / 5 s off.

5. The method according to claim 1, characterized in that, The ultrasonic treatment conditions in step (1) are: power of 240W and time of 5~45 min; preferably 5~15 min.

6. The method according to claim 1, characterized in that, The concentration of Antarctic krill protein amyloid fibrils in the solution in step (2) is 20~40 mg / mL.

7. The method according to claim 1, characterized in that, In step (2), the mass ratio of FeSO4·7H2O to Antarctic krill protein amyloid fiber is 1:

2.

8. Antarctic krill protein amyloid fiber-iron complex obtained by the method according to any one of claims 1 to 7.

9. The use of the Antarctic krill protein amyloid fiber-iron complex according to claim 8 in the preparation of iron-rich foods or iron supplements.

10. A method for improving the bioavailability of Antarctic krill protein amyloid fiber-iron complex, characterized in that, The method includes the following steps: (1) Disperse Antarctic krill protein powder in water to form a solution, adjust the pH, stir thoroughly, let stand, sonicate, heat, freeze dry to obtain Antarctic krill protein starch-like fibrils; Alternatively, Antarctic krill protein powder can be dispersed in water to form a solution, the pH adjusted, stirred thoroughly, allowed to stand, heated, sonicated, and freeze-dried to obtain Antarctic krill protein starch-like fibrils. (2) Add the Antarctic krill protein amyloid fibrils obtained in step (1) to water to form a solution, adjust the pH, add ascorbic acid and FeSO4·7H2O to react, centrifuge to collect the supernatant after the reaction, add anhydrous ethanol to stand and precipitate, centrifuge to collect the precipitate, wash and dry to obtain the Antarctic krill protein amyloid fibrils-iron complex.